U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX8706453: GSM4665450: SARS-CoV-2_Unmod_R1; Severe acute respiratory syndrome coronavirus 2; OTHER
1 ILLUMINA (NextSeq 500) run: 53.1M spots, 7.5G bases, 3.1Gb downloads

Submitted by: NCBI (GEO)
Study: Complete in vivo SHAPE-MaP structure of the SARS-CoV-2 genome
show Abstracthide Abstract
SHAPE-MaP structure probing experiment was performed on SARS-CoV-2 infected Vero cells at 4 days post infection with two biological replicates. For each replciate, SHAPE-MaP includes a sample treated with 2-methylnicotinic acid imidazolide acid (modified) or a minue reagent (unmodified). NAI preferentially reacts with unpaired bases in RNA, forming acylated bases. These modifications are encoded as mutation during reverse transcripatse and library preparation. After sequencing and alignment, the reactivity profiles of 'modified' and 'unmodified' samples are used to calculate SHAPE reactivity of each base Overall design: SHAPE-MaP on SARS-CoV-2 genomic RNA growing in Vero cells
Sample: SARS-CoV-2_Unmod_Rep1
SAMN15502292 • SRS6983244 • All experiments • All runs
Library:
Instrument: NextSeq 500
Strategy: OTHER
Source: TRANSCRIPTOMIC
Selection: other
Layout: PAIRED
Construction protocol: Trizol cDNA was prepared from modified RNA using gene-specific RT primers, followed by generation of amplicons with gene-specific primers. Nextera-XT kit was used for library construction
Experiment attributes:
GEO Accession: GSM4665450
Links:
Runs: 1 run, 53.1M spots, 7.5G bases, 3.1Gb
Run# of Spots# of BasesSizePublished
SRR1219262053,084,4627.5G3.1Gb2021-01-11

ID:
11328676

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...